Celldex Therapeutics buy BiotechBee
Start price
07.09.22
/
80%
€29.80
Target price
31.12.25
€50.00
Performance (%)
-18.12%
End price
14.12.24
€24.40
Summary
This prediction ended on 14.12.24 with a price of €24.40. The prediction for Celldex Therapeutics disappointed with a performance of -18.12%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celldex Therapeutics | -5.600% | -5.600% | -6.349% | -36.729% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
According to BiotechBee what are the pros and cons of Celldex Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Celldex Therapeutics diskutieren
Buy mit Kursziel 50,0